ENDRA Life Sciences (NDRA) Share-based Compensation (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Share-based Compensation of $574451.0 for Q1 2026, up 591.73% year-over-year from $83046.0 in Q1 2025, and up 28225.99% quarter-over-quarter from $2028.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Share-based Compensation (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Share-based Compensation for 11 consecutive years, with $574451.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 591.73% year-over-year to $574451.0; the TTM figure through Mar 2026 stood at $720774.0 (up 113.58% YoY), while the FY2025 annual figure was $329409.0, down 42.4% from the prior year.
- Share-based Compensation improved to $574451.0 in Q1 2026 per NDRA's latest filing, from $2028.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $909069.0 in Q3 2022 and bottomed at -$288537.0 in Q2 2022.
- Historically, Share-based Compensation has averaged $210118.4 across 5 years, with a median of $237279.0 in 2023.
- Annual changes were most pronounced in 2024 — Share-based Compensation plunged 114.58% — and 2026, when it jumped 591.73%.
- ENDRA Life Sciences' Share-based Compensation stood at $290769.0 in 2022, then dropped by 13.83% to $250557.0 in 2023, then sank by 58.22% to $104684.0 in 2024, then plunged by 98.06% to $2028.0 in 2025, then soared by 28225.99% to $574451.0 in 2026.
- Business Quant data shows NDRA's Share-based Compensation at $574451.0 in Q1 2026, $2028.0 in Q4 2025, and $104765.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 82.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 93.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 103.10 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 2.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 95.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 16.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 73.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 4.96 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 26.80 Mn |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | 3.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.02 Mn |
| Jun 30, 2026 | 3.02 Mn |
| Mar 31, 2026 | 3.02 Mn |
| Mar 31, 2026 | 3.02 Mn |
| Dec 31, 2025 | 2,028.00 |
| Dec 31, 2025 | 2,028.00 |
| Sep 30, 2025 | 104,765.00 |
| Sep 30, 2025 | 104,765.00 |
| Jun 30, 2025 | 39,530.00 |
| Jun 30, 2025 | 39,530.00 |
| Mar 31, 2025 | 83,046.00 |
| Mar 31, 2025 | 83,046.00 |
| Dec 31, 2024 | 104,684.00 |
| Dec 31, 2024 | 104,684.00 |
| Sep 30, 2024 | 279.00 |
| Sep 30, 2024 | 279.00 |
| Jun 30, 2024 | 679,187.00 |
| Jun 30, 2024 | 679,187.00 |
| Mar 31, 2024 | 317,497.00 |
| Mar 31, 2024 | 317,497.00 |